State Street Corp Sage Therapeutics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,474,862 shares of SAGE stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,474,862
Previous 4,494,796
44.94%
Holding current value
$14.4 Million
Previous $84.2 Million
68.09%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SAGE
# of Institutions
218Shares Held
47.9MCall Options Held
854KPut Options Held
195K-
Vanguard Group Inc Valley Forge, PA6.42MShares$37.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$31.8 Million0.99% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$30.3 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$25.9 Million0.81% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ1.43MShares$8.28 Million0.07% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $345M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...